Eaton Vance Management Jazz Pharmaceuticals PLC Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Eaton Vance Management holds 23,862 shares of JAZZ stock, worth $2.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,862

Previous 23,413 1.92%

Holding current value

$2.91 Million

Previous $3.65 Million 12.95%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $56,838 - $72,369	449 Added 1.92%	23,862 $3.18 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $833,540 - $992,901	-5,887 Reduced 20.09%	23,413 $3.65 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $2.46 Million - $3.04 Million	18,947 Added 183.01%	29,300 $4.56 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $306,507 - $372,478	-2,557 Reduced 19.81%	10,353 $1.27 Million
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $4.42 Million - $6.36 Million	-34,392 Reduced 72.71%	12,910 $1.59 Million
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $113,902 - $132,544	711 Added 1.53%	47,302 $8.4 Million
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $2.55 Million - $2.94 Million	16,968 Added 57.28%	46,591 $7.66 Million
Q4 2020 Feb 12, 2021	SELL	$140.71 - $165.05 $1.31 Million - $1.53 Million	-9,292 Reduced 23.88%	29,623 $4.89 Million
Q3 2020 Nov 13, 2020	SELL	$105.46 - $144.13 $527 - $720	-5 Reduced 0.01%	38,915 $5.55 Million
Q2 2020 Aug 13, 2020	BUY	$95.68 - $121.88 $749,652 - $954,929	7,835 Added 25.21%	38,920 $4.29 Million
Q1 2020 May 14, 2020	SELL	$87.74 - $152.74 $529,861 - $922,396	-6,039 Reduced 16.27%	31,085 $3.1 Million
Q4 2019 Feb 11, 2020	SELL	$117.65 - $153.73 $13.8 Million - $18 Million	-117,397 Reduced 75.97%	37,124 $5.54 Million
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $42,436 - $48,558	-339 Reduced 0.22%	154,521 $19.8 Million
Q2 2019 Aug 16, 2019	BUY	$125.55 - $144.48 $882,993 - $1.02 Million	7,033 Added 4.76%	154,860 $22.1 Million
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $5.99 Million - $7.03 Million	49,207 Added 49.9%	147,827 $21.1 Million
Q4 2018 Feb 07, 2019	SELL	$115.94 - $166.74 $1.85 Million - $2.66 Million	-15,959 Reduced 13.93%	98,620 $12.2 Million
Q3 2018 Nov 13, 2018	SELL	$161.01 - $180.57 $553,391 - $620,619	-3,437 Reduced 2.91%	114,579 $19.3 Million
Q2 2018 Aug 10, 2018	SELL	$146.33 - $183.18 $178,229 - $223,113	-1,218 Reduced 1.02%	118,016 $20.3 Million
Q1 2018 May 07, 2018	BUY	$135.59 - $157.16 $152,945 - $177,276	1,128 Added 0.96%	119,234 $18 Million
Q4 2017 Feb 12, 2018	SELL	$131.06 - $150.39 $475,616 - $545,765	-3,629 Reduced 2.98%	118,106 $15.9 Million
Q3 2017 Nov 13, 2017	BUY	$142.62 - $155.6 $17.4 Million - $18.9 Million	121,735	121,735 $17.8 Million

Others Institutions Holding JAZZ

# of Institutions

514

Shares Held

57.6M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.64B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Jazz Pharmaceuticals PLC Transaction History